Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Authors
Keywords
-
Journal
EPMA Journal
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-15
DOI
10.1007/s13167-020-00203-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of the Endocannabinoid System Following Central Nervous System Injury
- (2019) Juan Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
- (2019) Tarek Taha et al. ONCOLOGIST
- Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach
- (2019) Jiri Polivka et al. EPMA Journal
- Vaginal dryness: individualised patient profiles, risks and mitigating measures
- (2019) Vadym Goncharenko et al. EPMA Journal
- La plasticidad sináptica mediada por endocannabinoides y «trastornos por consumo de drogas»
- (2019) E. Fernández-Espejo et al. NEUROLOGIA
- Challenges to curing primary brain tumours
- (2019) Kenneth Aldape et al. Nature Reviews Clinical Oncology
- Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
- (2019) Eva Martínez-Pinilla et al. MOLECULAR NEUROBIOLOGY
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Cannabinoid receptor as a potential therapeutic target for Parkinson’s Disease
- (2019) Himadri Shekhaar Baul et al. BRAIN RESEARCH BULLETIN
- Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189
- (2019) Natalie M. Guley et al. EXPERIMENTAL EYE RESEARCH
- Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
- (2019) Marina Peball et al. JOURNAL OF NEURAL TRANSMISSION
- Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Anoop P Patel et al. LANCET NEUROLOGY
- Hippocampal Stratum Oriens Somatostatin-Positive Cells Undergo CB1-Dependent Long-Term Potentiation and Express Endocannabinoid Biosynthetic Enzymes
- (2019) Lindsey Friend et al. MOLECULES
- Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease
- (2019) Jenny Ceccarini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cell type specific impact of cannabinoid receptor signaling in somatosensory barrel map formation in mice
- (2019) Jana Hedrich et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
- (2019) Sonia Burgaz et al. MOLECULES
- Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis
- (2019) Jing Wang et al. Biomed Research International
- Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature
- (2019) RUDOLF LIKAR et al. ANTICANCER RESEARCH
- Cannabis in the treatment of traumatic brain injury: A primer for clinicians
- (2019) Karl Grenier et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Cannabis and Cannabinoid Biology in Stroke
- (2019) Sang-Ho Choi et al. STROKE
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Immunology
- Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments
- (2019) Cihat Uzunköprü et al. EPMA Journal
- Cannabis, alcohol and cigarette use during the acute post-concussion period
- (2019) David W. Lawrence et al. BRAIN INJURY
- Antinociceptive effects of treadmill exercise in a rat model of Parkinson's disease: The role of cannabinoid and opioid receptors
- (2019) K.H. Binda et al. BRAIN RESEARCH
- Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial
- (2019) Berzenn Urbi et al. BMJ Open
- Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
- (2019) Thorsten Rudroff Frontiers in Pharmacology
- Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
- (2019) Sinje Gehr et al. EPMA Journal
- Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene
- (2019) Marcia G. Honig et al. EXPERIMENTAL NEUROLOGY
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
- (2019) Glauce Crivelaro do Nascimento et al. NEUROPHARMACOLOGY
- The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
- (2019) Qi-Wen Han et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
- (2018) Shana M. Augustin et al. ACS Chemical Neuroscience
- Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats
- (2018) Jennifer A. Shearer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabis Use in Individuals With Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado
- (2018) Lenore A. Hawley et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
- (2018) Molly Braun et al. BRAIN BEHAVIOR AND IMMUNITY
- Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB 1 and CB 2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
- (2018) Gemma Navarro et al. BRAIN BEHAVIOR AND IMMUNITY
- The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
- (2018) Suzanne Nielsen et al. Current Neurology and Neuroscience Reports
- Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
- (2018) Talarico Giuseppina et al. Current Neuropharmacology
- Biphasic effects of THC in memory and cognition
- (2018) Edward J. Calabrese et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cannabis sativa (Marijuana) alters blood chemistry and the cytoarchitecture of some organs in Sprague Dawley rat models
- (2018) Nosarieme Omoregie Abey FOOD AND CHEMICAL TOXICOLOGY
- Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer’s Disease-Like Pathology
- (2018) Anne-Caroline Schmöle et al. JOURNAL OF ALZHEIMERS DISEASE
- A TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitors
- (2018) Taasin Srivastava et al. JOURNAL OF CLINICAL INVESTIGATION
- Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
- (2018) Concepción García et al. Journal of Neuroinflammation
- Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
- (2018) Yosef Sarne et al. NEUROBIOLOGY OF AGING
- [ 18 F]FMPEP- d 2 PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease
- (2018) Jatta S. Takkinen et al. NEUROBIOLOGY OF AGING
- Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease
- (2018) Francisco Navarrete et al. Neurotherapeutics
- Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer’s disease-like mice overexpressing the human mutant amyloid precursor protein
- (2018) Mauro Maccarrone et al. PHARMACOLOGICAL RESEARCH
- The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
- (2018) Valerio Chiurchiù et al. PROGRESS IN NEUROBIOLOGY
- Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
- (2018) Wei Xiang et al. Nature Communications
- Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
- (2018) Claudia A. Dumitru et al. Frontiers in Molecular Neuroscience
- Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
- (2018) Olga Golubnitschaja et al. EPMA Journal
- Preventive, predictive, and personalized medicine for effective and affordable cancer care
- (2018) Jaak Ph. Janssens et al. EPMA Journal
- The crucial role of multiomic approach in cancer research and clinically relevant outcomes
- (2018) Miaolong Lu et al. EPMA Journal
- Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
- (2018) Israel López-Valero et al. BIOCHEMICAL PHARMACOLOGY
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
- (2018) Iván Manuel et al. JOURNAL OF ALZHEIMERS DISEASE
- Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model
- (2018) Mustafa Nazıroğlu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity
- (2018) Libat Weizman et al. NEUROLOGY
- Medical Use of Cannabinoids
- (2018) Ana Isabel Fraguas-Sánchez et al. DRUGS
- Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
- (2018) Aida Habib et al. GUT
- Therapeutic effect of a novel fatty acid amide hydrolase inhibitor PF04457845 in the repetitive closed head injury mouse model
- (2018) Prabhuanand Selvaraj et al. JOURNAL OF NEUROTRAUMA
- Global Burden of Neurological Disorders: From Global Burden of Disease Estimates to Actions
- (2018) Valery L. Feigin et al. NEUROEPIDEMIOLOGY
- The Endocannabinoid System and Oligodendrocytes in Health and Disease
- (2018) Alexander A. Ilyasov et al. Frontiers in Neuroscience
- Predictive and individualized management of stroke—success story in Czech Republic
- (2018) Jiri Polivka et al. EPMA Journal
- Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
- (2018) Marco Gentili et al. PHARMACOLOGICAL RESEARCH
- Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model
- (2018) Erika Simmerman et al. JOURNAL OF SURGICAL RESEARCH
- Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet
- (2017) Gaetano Terrone et al. EPILEPSIA
- Strokes are possible complications of cannabinoids use
- (2017) Valérie Wolff et al. EPILEPSY & BEHAVIOR
- Role of cannabis in digestive disorders
- (2017) Hemant Goyal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- An update on the advancements in the treatment of agitation in Alzheimer’s disease
- (2017) Anton P. Porsteinsson et al. EXPERT OPINION ON PHARMACOTHERAPY
- Emotion regulation deficits in regular marijuana users
- (2017) Kaeli Zimmermann et al. HUMAN BRAIN MAPPING
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
- (2017) Thaís Alberti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury
- (2017) Molly Braun et al. JOURNAL OF IMMUNOLOGY
- Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
- (2017) Pasquale Annunziata et al. JOURNAL OF NEUROIMMUNOLOGY
- Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability
- (2017) Jacques Mayeux et al. JOURNAL OF NEUROTRAUMA
- Operative Treatment of 2-Part Surgical Neck Fracture of the Humerus
- (2017) Wonyong Lee et al. JOURNAL OF ORTHOPAEDIC TRAUMA
- Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
- (2017) Lin Wang et al. MOLECULAR NEUROBIOLOGY
- Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors
- (2017) Jian Zhang et al. MOLECULAR NEUROBIOLOGY
- A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
- (2017) Andras Bilkei-Gorzo et al. NATURE MEDICINE
- The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy
- (2017) Paula Province Warren et al. NEUROCASE
- Efecto del inhibidor de amida hidrolasa de ácidos grasos en el daño neuronal dopaminérgico inducido por MPTP
- (2017) J.M. Viveros-Paredes et al. NEUROLOGIA
- Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
- (2017) Maria Ceprián et al. NEUROPHARMACOLOGY
- Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy
- (2017) Anna-Maria Szczesniak et al. NEUROPHARMACOLOGY
- The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
- (2017) Roberto Colangeli et al. Scientific Reports
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
- (2017) Salahaden R. Sultan et al. Frontiers in Pharmacology
- Endocannabinoids: A Promising Impact for Traumatic Brain Injury
- (2017) Lesley D. Schurman et al. Frontiers in Pharmacology
- Role of cannabis in cardiovascular disorders
- (2017) Hemant Goyal et al. Journal of Thoracic Disease
- Cannabis and Multiple Sclerosis—The Way Forward
- (2017) Thorsten Rudroff et al. Frontiers in Neurology
- Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry
- (2017) Azmeraw T. Amare et al. EPMA Journal
- Targeting the Endocannabinoid System in Alzheimer's Disease
- (2017) Jeremy Koppel et al. JOURNAL OF ALZHEIMERS DISEASE
- Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
- (2016) Sonia Hernández-Tiedra et al. Autophagy
- Absence of gut microbiota influences lipopolysaccharide-induced behavioral changes in mice
- (2016) Alline C. Campos et al. BEHAVIOURAL BRAIN RESEARCH
- An Introduction to the Endogenous Cannabinoid System
- (2016) Hui-Chen Lu et al. BIOLOGICAL PSYCHIATRY
- Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease
- (2016) Marta Celorrio et al. BRAIN BEHAVIOR AND IMMUNITY
- Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors
- (2016) William H Hind et al. BRITISH JOURNAL OF PHARMACOLOGY
- Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
- (2016) Rawaha Ahmad et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury
- (2016) Ana Belen Lopez-Rodriguez et al. EXPERIMENTAL NEUROLOGY
- Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease
- (2016) Ruth M. Concannon et al. EXPERIMENTAL NEUROLOGY
- Cannabinoids, inflammation, and fibrosis
- (2016) Robert B. Zurier et al. FASEB JOURNAL
- Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
- (2016) Assaf Shelef et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Prognostic factors in C9orf72 amyotrophic lateral sclerosis
- (2016) José Manuel Matamala et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease
- (2016) Shreesh Ojha et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
- (2016) A. Vanessa Stempel et al. NEURON
- Stimulation of brain glucose uptake by cannabinoid CB 2 receptors and its therapeutic potential in Alzheimer's disease
- (2016) Attila Köfalvi et al. NEUROPHARMACOLOGY
- Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons
- (2016) Önder Albayram et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease
- (2016) Shalini Jayant et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
- (2016) F.F. Peres et al. SCHIZOPHRENIA RESEARCH
- Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
- (2016) Isabel Bravo-Ferrer et al. STROKE
- Association of anandamide with altered binocular depth inversion illusion in schizophrenia
- (2016) Anne R. Reuter et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis
- (2016) Marie-Louise Zeissler et al. Oncotarget
- VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
- (2016) Javier Díaz-Alonso et al. Scientific Reports
- CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
- (2016) Ester Aso et al. Frontiers in Neuroscience
- Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
- (2016) Erin M. Rock et al. Frontiers in Pharmacology
- Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016
- (2016) Olga Golubnitschaja et al. EPMA Journal
- Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
- (2016) Yilin Tang et al. PLoS One
- Salvia miltiorrhiza extract protects white matter and the hippocampus from damage induced by chronic cerebral hypoperfusion in rats
- (2015) Min-Soo Kim et al. BMC Complementary and Alternative Medicine
- Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling
- (2015) Ki Mo Lee et al. BMC Complementary and Alternative Medicine
- Endocannabinoids modulate human blood-brain barrier permeabilityin vitro
- (2015) William H Hind et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation
- (2015) J.T. Toguri et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
- (2015) Celina S. Liu et al. CNS DRUGS
- Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
- (2015) Ruth M. Concannon et al. EXPERIMENTAL NEUROLOGY
- Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease
- (2015) Francesco Panza et al. EXPERT OPINION ON PHARMACOTHERAPY
- The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
- (2015) Demetrios Moris et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
- (2015) Sven G Meuth et al. Expert Review of Neurotherapeutics
- Medical Marijuana
- (2015) Amy E. Thompson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Use of Cannabinoids
- (2015) Igor Grant JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Use of Cannabinoids
- (2015) Michael E. Schatman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury
- (2015) Jian Zhang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Cannabinoids in Experimental Stroke: A Systematic Review and Meta-Analysis
- (2015) Timothy J England et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Endocannabinoid Degradation Inhibition Improves Neurobehavioral Function, Blood–Brain Barrier Integrity, and Neuroinflammation following Mild Traumatic Brain Injury
- (2015) Paige S. Katz et al. JOURNAL OF NEUROTRAUMA
- The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
- (2015) Jan van Amsterdam et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Endocannabinoid signalling and the deteriorating brain
- (2015) Vincenzo Di Marzo et al. NATURE REVIEWS NEUROSCIENCE
- Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice
- (2015) E.L. von Rüden et al. NEUROBIOLOGY OF DISEASE
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium
- (2015) Brian C. Shonesy et al. NEUROPHARMACOLOGY
- Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
- (2015) Y. Li et al. NEUROSCIENCE
- Changes in Cannabinoid Receptors, Aquaporin 4 and Vimentin Expression after Traumatic Brain Injury in Adolescent Male Mice. Association with Edema and Neurological Deficit
- (2015) Ana Belen Lopez-Rodriguez et al. PLoS One
- Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
- (2015) Paula Suárez-Pinilla et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
- (2015) E Singer et al. Cell Death & Disease
- Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
- (2015) Sven G Meuth et al. Expert Review of Neurotherapeutics
- Time-Dependent Protection of CB2 Receptor Agonist in Stroke
- (2015) Seong-Jin Yu et al. PLoS One
- Cannabis and Schizophrenia
- (2015) J. A. Pushpa-Rajah et al. SCHIZOPHRENIA BULLETIN
- Efficacy and safety of medical cannabinoids in older subjects: A systematic review
- (2014) G.A.H. van den Elsen et al. AGEING RESEARCH REVIEWS
- Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
- (2014) Salvador Sierra et al. Brain Structure & Function
- Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease
- (2014) Itay Lotan et al. CLINICAL NEUROPHARMACOLOGY
- Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93ATransgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
- (2014) Miguel Moreno-Martet et al. CNS Neuroscience & Therapeutics
- Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
- (2014) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists
- (2014) A.C. Pascual et al. EXPERIMENTAL GERONTOLOGY
- CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
- (2014) János Haskó et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
- (2014) Gareth Pryce et al. Journal of Neuroimmune Pharmacology
- Neuroprotective Potential of Adenosine A2Aand Cannabinoid CB1Receptor Antagonists in an Animal Model of Parkinson Disease
- (2014) Silvia Cerri et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage
- (2014) Miriam Fishbein-Kaminietsky et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis
- (2014) Paula de Robles et al. NEURO-ONCOLOGY
- The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
- (2014) Diana Fernández-Suárez et al. NEUROBIOLOGY OF AGING
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury
- (2014) Flaubert Tchantchou et al. NEUROPHARMACOLOGY
- Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
- (2014) Sara Valdeolivas et al. Neurotherapeutics
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
- (2014) Daniel J. Hermanson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neurobehavioral, neuropathological and biochemical profiles in a novel mouse model of co-morbid post-traumatic stress disorder and mild traumatic brain injury
- (2014) Joseph O. Ojo et al. Frontiers in Behavioral Neuroscience
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies
- (2014) Guoqiang Xing et al. Frontiers in Neurology
- Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration
- (2014) Richard P Tobin et al. Acta Neuropathologica Communications
- Role of cannabinoid CB2receptor in the reinforcing actions of ethanol
- (2013) Antonio Ortega-Álvaro et al. ADDICTION BIOLOGY
- Cannabinoid Receptor 2 Activation
- (2013) Shilpa J. Buch AMERICAN JOURNAL OF PATHOLOGY
- Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
- (2013) Slava Rom et al. AMERICAN JOURNAL OF PATHOLOGY
- Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
- (2013) N Murataeva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Changes in CB1and CB2receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
- (2013) Carmen Rodríguez-Cueto et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
- (2013) Emelie Janefjord et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
- (2013) Weimin Kong et al. CELLULAR IMMUNOLOGY
- CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice
- (2013) A. B. Lopez-Rodriguez et al. CEREBRAL CORTEX
- Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain
- (2013) Kazuhito Tsuboi et al. CNS & Neurological Disorders-Drug Targets
- Differential expression and functional role of cannabinoid genes in alcohol users
- (2013) Marisela Agudelo et al. DRUG AND ALCOHOL DEPENDENCE
- In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
- (2013) Rawaha Ahmad et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Modulating the endocannabinoid system in human health and disease - successes and failures
- (2013) Pál Pacher et al. FEBS Journal
- Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model
- (2013) Ivana Hradilová Svíženská et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
- (2013) Mark Broeders et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
- (2013) Daniel J Hermanson et al. NATURE NEUROSCIENCE
- Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina
- (2013) Bruno Cécyre et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing and Physical Effects of Nicotine
- (2013) Francisco Navarrete et al. NEUROPSYCHOPHARMACOLOGY
- Mechanism of platelet activation induced by endocannabinoids in blood and plasma
- (2013) S. Annette Brantl et al. PLATELETS
- Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
- (2013) Carolina Muguruza et al. SCHIZOPHRENIA RESEARCH
- Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance
- (2012) Sarah Dubreucq et al. BIOLOGICAL PSYCHIATRY
- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
- (2012) Massimo Nabissi et al. CARCINOGENESIS
- The Endocannabinoid System and Schizophrenia: Integration of Evidence
- (2012) Erica Zamberletti et al. CURRENT PHARMACEUTICAL DESIGN
- Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
- (2012) Raquel Levin et al. CURRENT PHARMACEUTICAL DESIGN
- The therapeutic potential of the endocannabinoid system for Alzheimer's disease
- (2012) Tim Karl et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabinoid Receptors CB1and CB2Form Functional Heteromers in Brain
- (2012) Lucía Callén et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
- (2012) Peter S. Amenta et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Selective Inhibition of Alpha/Beta-Hydrolase Domain 6 Attenuates Neurodegeneration, Alleviates Blood Brain Barrier Breakdown, and Improves Functional Recovery in a Mouse Model of Traumatic Brain Injury
- (2012) Flaubert Tchantchou et al. JOURNAL OF NEUROTRAUMA
- Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model
- (2012) L. E. Goldstein et al. Science Translational Medicine
- A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease
- (2012) Justin R. Piro et al. Cell Reports
- Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
- (2012) Rongqing Chen et al. Cell Reports
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management
- (2012) Joana Meireles et al. Frontiers in Neurology
- General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
- (2012) Olga Golubnitschaja et al. EPMA Journal
- Endocannabinoid system dysfunction in mood and related disorders
- (2011) C. H. Ashton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage
- (2011) Fadi Assaf et al. BEHAVIOURAL BRAIN RESEARCH
- In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis
- (2011) K. Goffin et al. BRAIN
- Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
- (2011) Jan Mulder et al. BRAIN
- Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates
- (2011) Noriko Suzuki et al. BRAIN RESEARCH
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoids and traumatic brain injury
- (2011) Esther Shohami et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice
- (2011) Francisco Navarrete et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
- (2011) María S García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids, endocannabinoids, and cancer
- (2011) Daniel J. Hermanson et al. CANCER AND METASTASIS REVIEWS
- Estradiol Decreases Cortical Reactive Astrogliosis after Brain Injury by a Mechanism Involving Cannabinoid Receptors
- (2011) A. B. Lopez Rodriguez et al. CEREBRAL CORTEX
- Role of Cannabinoids in Multiple Sclerosis
- (2011) John P. Zajicek et al. CNS DRUGS
- Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
- (2011) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
- (2011) Emmanuel S Onaivi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
- (2011) Zheng-Xiong Xi et al. NATURE NEUROSCIENCE
- Clinical diagnosis and management of amyotrophic lateral sclerosis
- (2011) Orla Hardiman et al. Nature Reviews Neurology
- Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
- (2011) Koen Van Laere et al. NEUROBIOLOGY OF AGING
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Huntington's disease: a clinical review
- (2011) Raymund A.C. Roos Orphanet Journal of Rare Diseases
- Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
- (2011) T. Tsetsenis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
- (2011) Beng-Choon Ho et al. SCHIZOPHRENIA RESEARCH
- Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
- (2011) D. K. Nomura et al. SCIENCE
- Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
- (2011) Juan G. Zarruk et al. STROKE
- Effects of endocannabinoid system modulation on cognitive and emotional behavior
- (2011) Claudio Zanettini Frontiers in Behavioral Neuroscience
- Acute management of acquired brain injury part II: An evidence-based review of pharmacological interventions
- (2010) Matthew J. Meyer et al. BRAIN INJURY
- 2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors
- (2010) Oliver P. Keown et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The endocannabinoid system as a target for the treatment of neurodegenerative disease
- (2010) Emma L Scotter et al. BRITISH JOURNAL OF PHARMACOLOGY
- Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
- (2010) MS García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner
- (2010) Massimo Nabissi et al. CARCINOGENESIS
- Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
- (2010) Patricia Reggio CURRENT MEDICINAL CHEMISTRY
- Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
- (2010) Yan Zhao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
- (2010) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo
- (2010) Gabriel M. Simon et al. Molecular BioSystems
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Homeostatic changes of the endocannabinoid system in Parkinson's disease
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
- (2010) Jason R Clapper et al. NATURE NEUROSCIENCE
- Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
- (2010) Victoria E. Johnson et al. NATURE REVIEWS NEUROSCIENCE
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- The Maturation of GABAergic Transmission in Visual Cortex Requires Endocannabinoid-Mediated LTD of Inhibitory Inputs during a Critical Period
- (2010) Bin Jiang et al. NEURON
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA
- (2010) Jenny Ceccarini et al. SCHIZOPHRENIA RESEARCH
- The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
- (2010) Josee Guindon et al. Current Molecular Pharmacology
- Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence
- (2009) Martin Cohen et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-Inhibiting Mechanism
- (2009) Kazuhide Hayakawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
- (2009) Glenn Schwarcz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cannabinoid CB1 Receptor-Dependent Long-Term Depression in Autaptic Excitatory Neurons
- (2009) Ryan Kellogg et al. JOURNAL OF NEUROPHYSIOLOGY
- Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
- (2009) M. T. Viscomi et al. JOURNAL OF NEUROSCIENCE
- Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
- (2009) S. G. Kinsey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cognitive decline in Parkinson’s disease: A prospective longitudinal study
- (2009) DINO MUSLIMOVIĆ et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Self-modulation of neocortical pyramidal neurons by endocannabinoids
- (2009) Silvia Marinelli et al. NATURE NEUROSCIENCE
- Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease
- (2009) M.J. Dowie et al. NEUROSCIENCE
- Detection of behavioral alterations and learning deficits in mice lacking synaptophysin
- (2009) U. Schmitt et al. NEUROSCIENCE
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Role of cannabis and endocannabinoids in the genesis of schizophrenia
- (2009) Emilio Fernandez-Espejo et al. PSYCHOPHARMACOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Pretreatment With Electroacupuncture Induces Rapid Tolerance to Focal Cerebral Ischemia Through Regulation of Endocannabinoid System
- (2009) Qiang Wang et al. STROKE
- Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells
- (2008) Gil Galanti et al. ACTA ONCOLOGICA
- Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia
- (2008) Iván Chavarría-Siles et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- The Endocannabinoid System in Parkinsons Disease
- (2008) Massimiliano Di Filippo et al. CURRENT PHARMACEUTICAL DESIGN
- The Endocannabinoid System in Huntingtons Disease
- (2008) M. Pazos et al. CURRENT PHARMACEUTICAL DESIGN
- Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
- (2008) Cecilia Hillard CURRENT PHARMACEUTICAL DESIGN
- The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses
- (2008) Tiziana Bisogno et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model
- (2008) Sanneke A.M. van Vliet et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
- (2008) Daniela Vigano et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis
- (2008) M Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
- (2008) S. Marinelli et al. JOURNAL OF NEUROSCIENCE
- Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
- (2008) A. Ludanyi et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury
- (2008) M. Zhang et al. NEUROSCIENCE
- Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
- (2008) Christophe Mallet et al. PAIN
- Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
- (2008) Francisco J Alvarez et al. PEDIATRIC RESEARCH
- Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
- (2008) I SVIZENSKA et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats
- (2008) Nico Wegener et al. PSYCHOPHARMACOLOGY
- The Impact of Substance Abuse on Mortality in Patients With Severe Traumatic Brain Injury
- (2008) Kristine OʼPhelan et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Prostamides (prostaglandin-ethanolamides) and their pharmacology
- (2007) D F Woodward et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
- (2007) E J Rahn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
- (2007) G Pryce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alzheimer's disease; taking the edge off with cannabinoids?
- (2007) V A Campbell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anhedonia and Social Adaptation Predict Substance Abuse Evolution in Dual Diagnosis Schizophrenia
- (2007) Stéphane Potvin et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started